ALPS Medical Breakthroughs ETF Rating $32.84 +0.56 (+1.72%) As of 09:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.96Holdings in SBIO have an aggregate rating of Moderate Buy based on 288 analyst ratings issued in the past year covering 25 companies (58.6% of the portfolio).SBIO Aggregate Price Target$32.28High Prediction$32.28Average Prediction$32.28Low Prediction$32.28Holdings in SBIO have an aggregate price target of $32.28 and a range of $32.28 to $32.28 covering 25 companies (58.6% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.46%RYTMRhythm Pharmaceuticals$88.39+2.0%3.1902 of 5 stars3.07$91.00 3.0%15Trending NewsInsider TradeAnalyst Revision3.38%NUVLNuvalent$82.01+1.3%3.3574 of 5 stars3.17$119.60 45.8%12Insider Trade3.38%AXSMAxsome Therapeutics$111.14+2.0%4.722 of 5 stars3.06$172.33 55.1%16Analyst Revision3.14%ALKSAlkermes$30.27-0.6%4.8086 of 5 stars2.83$40.00 32.2%12Positive News2.92%PCVXVaxcyte$36.22+0.8%1.8293 of 5 stars3.10$136.50 276.9%10Positive News2.78%CYTKCytokinetics$37.53+1.4%3.9745 of 5 stars2.93$70.92 89.0%152.68%KRYSKrystal Biotech$148.57-0.8%4.6678 of 5 stars3.00$213.75 43.9%9Insider TradeAnalyst Revision2.60%MTSRMetsera$38.72-1.4%N/A3.00$55.00 42.0%5Gap Down2.58%AKROAkero Therapeutics$52.43+1.7%3.5247 of 5 stars3.00$82.50 57.4%6Insider Trade2.55%MRUSMerus$55.46+1.8%1.9153 of 5 stars3.14$84.64 52.6%14Analyst UpgradeInsider Trade2.42%PTCTPTC Therapeutics$49.08+1.1%4.5578 of 5 stars2.67$65.00 32.5%15Positive News2.39%ACLXArcellx$69.97+1.4%2.561 of 5 stars3.07$111.23 59.0%15Positive News2.39%RNAAvidity Biosciences$34.16+8.6%2.1857 of 5 stars3.06$66.35 94.3%17Analyst Forecast2.32%ZLABZai Lab$34.37+5.0%3.3288 of 5 stars2.80$54.28 57.9%5Positive News2.21%ACADACADIA Pharmaceuticals$21.09+0.5%4.7174 of 5 stars2.71$27.88 32.2%17Positive NewsAnalyst Revision2.20%VKTXViking Therapeutics$30.98-0.4%4.5871 of 5 stars3.00$87.15 181.4%14Positive News2.06%PTGXProtagonist Therapeutics$54.37+2.6%1.5923 of 5 stars3.00$66.10 21.6%10Positive News1.96%MLTXMoonLake Immunotherapeutics$50.04+2.1%1.7101 of 5 stars3.00$74.50 48.9%7News Coverage1.88%CRNXCrinetics Pharmaceuticals$33.30+4.3%3.4696 of 5 stars2.80$69.50 108.7%101.64%MIRMMirum Pharmaceuticals$53.51+1.6%3.2042 of 5 stars3.13$65.50 22.4%8Analyst Forecast1.59%ARWRArrowhead Pharmaceuticals$18.52+1.1%3.5835 of 5 stars2.75$43.71 136.1%8Gap Down1.56%XENEXenon Pharmaceuticals$32.56-1.3%3.4619 of 5 stars3.00$54.82 68.4%121.54%APLSApellis Pharmaceuticals$19.97+2.7%4.1826 of 5 stars2.62$39.79 99.2%211.52%NAMSNewAmsterdam Pharma$21.66+0.5%2.7299 of 5 stars3.00$42.89 98.1%81.43%AGIOAgios Pharmaceuticals$39.16+0.3%4.4395 of 5 stars2.71$58.60 49.7%7Insider TradeAnalyst Revision This page (NYSEARCA:SBIO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
